Discover
ALXO
ALX Oncology Holdings Inc.
2.06
2 x 1.50
2 x 2.54
bid
ask
-
0.01
0.48%
2 @ 04:00 PM
2.09 +0.03 (1.33%)
| Ytd | 82.30% | |
| 1y | 375.75% |
1.98
day range
2.11
0.42
52 week range
2.66
| Open | 2.04 | Prev Close | 2.07 | Low | 1.98 | High | 2.11 | Mkt Cap | 277.20M |
| Vol | 1.23M | Avg Vol | 1.42M | EPS | -1.49 | P/E | N/A | Forward P/E | -0.68 |
| Beta | 1.04 | Short Ratio | 8.58 | Inst. Own | 88.21% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-08 | 50-d Avg | 1.80 | 200-d Avg | 1.71 | 1yr Est | 7.67 |
| Income Statement | |||
| Operating Expenses | 18.97M | ||
| Research and Development Expense | 13.61M | ||
| Selling, General and Administrative Expense | 5.36M | ||
| Operating Income | -18.97M | ||
| Interest Expense | 331.00K | ||
| Net Income | -17.93M | ||
| Net Income Common Stock | -17.93M | ||
| Net Income Common Stock (USD) | -17.93M | ||
| Consolidated Income | -17.93M | ||
| Earnings per Basic Share | -0.17 | ||
| Earnings per Basic Share (USD) | -0.17 | ||
| Earnings per Diluted Share | -0.17 | ||
| Earning Before Interest & Taxes (EBIT) | -17.60M | ||
| Earning Before Interest & Taxes (USD) | -17.60M | ||
| Weighted Average Shares | 104.57M | ||
| Weighted Average Shares Diluted | 104.57M | ||
| Balance Sheet | |||
| Cash and Equivalents | 32.28M | ||
| Cash and Equivalents (USD) | 32.28M | ||
| Investments | 136.82M | ||
| Investments Current | 108.04M | ||
| Investments Non-Current | 28.78M | ||
| Current Assets | 145.56M | ||
| Property, Plant & Equipment Net | 1.05M | ||
| Total Assets | 178.33M | ||
| Debt Current | 5.22M | ||
| Total Debt | 8.51M | ||
| Current Liabilities | 20.18M | ||
| Debt Non-Current | 3.30M | ||
| Total Liabilities | 26.98M | ||
| Accumulated Retained Earnings (Deficit) | -740.74M | ||
| Accumulated Other Comprehensive Income | -245.00K | ||
| Shareholders Equity | 151.35M | ||
| Shareholders Equity (USD) | 151.35M | ||
| Assets Non-Current | 32.76M | ||
| Total Debt (USD) | 8.51M | ||
| Liabilities Non-Current | 6.80M | ||
| Trade and Non-Trade Payables | 3.85M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 150.00K | ||
| Net Cash Flow from Financing | 139.60M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 15.91M | ||
| Capital Expenditure | -50.00K | ||
| Issuance (Purchase) of Equity Shares | 141.20M | ||
| Issuance (Repayment) of Debt Securities | -1.61M | ||
| Net Cash Flow from Investing | -105.04M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -104.99M | ||
| Net Cash Flow from Operations | -18.65M | ||
| Share Based Compensation | 2.51M | ||